Related Experiment Video
Updated: Apr 5, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma
Xinkui Xiong1, Daoyi Sun1, Hao Chai1
1Liver Transplantation Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China; Key Laboratory of Living Donor Liver Transplantation, Ministry of Public Health, Nanjing, Jiangsu Province, China.
Abstract:
The dysregulation of micro (mi)RNAs is associated with cancer development. The miRNA miR-145 is downregulated in intrahepatic cholangiocarcinoma (ICC); however, its precise role in tumor progression has not yet been elucidated. Novel (nua) kinase family (NUAK)1 functions as an oncogene in various cancers and is a putative target of miR-145 regulation. In this study, we investigated the regulation of NUAK1 by miR-145 in ICC. We found that miR-145 level was significantly decreased in ICC tissue and cell lines, which corresponded with an increase in NUAK1 expression. NUAK1 was found to be a direct target of miR-145 regulation. The overexpression of miR-145 in ICC cell lines inhibited proliferation, growth, and invasion by suppressing NUAK1 expression, which was associated with a decrease in Akt signaling and matrix metalloproteinase protein expression. Similar results were observed by inhibiting NUAK1 expression. These results demonstrate that miR-145 can prevent ICC progression by targeting NUAK1 and its downstream effectors, and can therefore be useful for clinical diagnosis and targeted therapy of ICC.
Insights
MicroRNA miR-145 is decreased in intrahepatic cholangiocarcinoma (ICC), suppressing tumor growth. Restoring miR-145 inhibits ICC progression by targeting NUAK1, offering potential for diagnosis and therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNA (miRNA) dysregulation is linked to cancer development.
- miR-145 is downregulated in intrahepatic cholangiocarcinoma (ICC), but its role is unclear.
- NUAK1 acts as an oncogene and is a potential target of miR-145.
Purpose of the Study:
- To investigate the regulatory relationship between miR-145 and NUAK1 in ICC.
- To determine the functional impact of miR-145/NUAK1 axis on ICC progression.
Main Methods:
- Quantitative real-time PCR to measure miR-145 and NUAK1 expression in ICC tissues and cell lines.
- Luciferase reporter assays to confirm direct targeting of NUAK1 by miR-145.
- Cell proliferation, growth, and invasion assays in ICC cell lines with miR-145 overexpression or NUAK1 inhibition.
- Western blotting to assess Akt signaling and matrix metalloproteinase expression.
Main Results:
- miR-145 expression was significantly decreased in ICC tissues and cell lines, inversely correlated with NUAK1 expression.
- NUAK1 was validated as a direct target of miR-145.
- Overexpression of miR-145 suppressed ICC cell proliferation, growth, and invasion by downregulating NUAK1.
- miR-145/NUAK1 inhibition reduced Akt signaling and matrix metalloproteinase expression, mirroring effects of NUAK1 suppression.
Conclusions:
- miR-145 inhibits ICC progression by targeting NUAK1 and its downstream pathways.
- The miR-145/NUAK1 axis is a critical regulator of ICC tumor growth and invasion.
- miR-145 holds potential as a biomarker for ICC diagnosis and a therapeutic target.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

